MENA Pharmaceutical Market Will Be Worth US$23.7bn By 2014

In BMI's recent analysis of the Gulf Co-operation Council (GCC) pharmaceutical market, we highlighted Saudi Arabia and the UAE as the biggest medicine spenders - reaching values of US$3.8bn and US$2.7bn by 2014, respectively. In BMI's Middle East and North Africa (MENA) coverage, Algeria, Iran and Egypt join Saudi and the UAE to form the most influential and attractive pharmaceutical markets in the region.

To read the full article, please take a trial.